Study: Breast cancer care decisions depend on insurance plans for some | The city where plastic surgery is king | HHS releases draft rule for MU stage 3
 
Advertisement

March 24, 2015
CONNECT WITH SMARTBRIEF LinkedInFacebookTwitterGoogle+
Plastic Surgery SmartBrief
SIGN UP|FORWARD|ARCHIVE|ADVERTISE

In the News
Study: Breast cancer care decisions depend on insurance plans for some
Black and Hispanic breast cancer patients are more likely than their white peers to choose a surgeon and hospital based on health insurance networks and physician referrals, according to a study published in JAMA Oncology. White patients were more likely to consider hospital and surgeon reputation in their care choices, researchers found. HealthDay News (3/19)
Share: LinkedInTwitterFacebookGoogle+Email
The city where plastic surgery is king
Seoul, South Korea, is the world's cosmetic-surgery capital, with up to 500 clinics within 1 square mile of the city's "Improvement Quarter." Among the explanations for the country's love affair with plastic surgery is its heritage of Confucianism. "In Korea, we don't care what you think about yourself. Other people's evaluations of you matter more," says Eunkook Suh, a professor. The New Yorker (tiered subscription model) (3/23)
Share: LinkedInTwitterFacebookGoogle+Email
The Key To Positive Cash Flow
Every business is cyclical with cash flow ups and downs. The key is to find a way to keep the cash coming in as predictably as possible. Seem impossible? Well it's not. There are systems and processes that make it easier to collect the cash you've earned so your small business can grow. Learn how these small-business owners set up their businesses for success.
Advertisement

Practice ManagementAdvertisement
HHS releases draft rule for MU stage 3
HHS issued its proposed rule for stage 3 of meaningful use on Friday. The draft lays out the standards that providers will have to meet to receive Medicare and Medicaid EHR incentives and to avoid penalties. Stage 3 requirements include the use of five clinical decision support interventions. Feedback on the proposal will be accepted through May 29. HealthLeaders Media (3/23), AuntMinnie.com (free registration) (3/20), Modern Healthcare (tiered subscription model) (3/20)
Share: LinkedInTwitterFacebookGoogle+Email
Report shows cost efficiency of switching to electronic transactions
A CAQH report revealed that the health care industry could save $8 billion every year by converting manual business transactions, such as claims submission and benefit verification, to electronic transactions. The estimated cost for providers per electronic transaction is $1.60, compared with over $5 for a manual transaction, the report said. BeckersHospitalReview.com (3/23)
Share: LinkedInTwitterFacebookGoogle+Email
Whitepaper: SDN: How do you get there from here?
Are the growing data needs of mobile, cloud, big data and social threatening today's enterprise networks? Scalable processes, a phased integration approach and the appetite to optimize over time are key components of a modern network. It's how agile organizations prepare for the data needs of tomorrow.
Explore the whitepaper to start down the path toward SDN.
Advertisement

Health Quality & Advocacy
France requires cancer warning on silicone breast implants
Silicone breast implants in France must now carry a warning about the risk for anaplastic large cell lymphoma, according to the Ministry of Social Affairs, Health and Women's Rights. ALCL in the breast is diagnosed in 3 in 100 million American women each year, according to the National Cancer Institute. Though the condition is extremely rare, researchers are working to identify possible causes, screening methods, diagnostic evaluation methods and recommended treatments, says plastic surgeon Michael Edwards. Medscape (free registration) (3/24)
Share: LinkedInTwitterFacebookGoogle+Email
Research & Technology
Injectable body-contouring drug moves to late-stage testing
Neothetics is planning Phase III trials of a compound called LIPO-202 for abdominal fat reduction and body contouring. The compound is an injectable form of salmeterol xinafoate, a beta-2 adrenergic receptor approved for use in asthma inhalers. Modern Medicine/Cosmetic Surgery Times (3/17)
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
Our greatest weakness lies in giving up. The most certain way to succeed is always to try just one more time."
-- Thomas Edison,
inventor
Share: LinkedInTwitterFacebookGoogle+Email
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Lisa Gough
Advertising:  Rebecca Adelson
  P: 202.618.5665
 
 

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information